Home
>
National Drug Code (NDC)
>
CIMETIDINE
CIMETIDINE - 21695-531-21 - (CIMETIDINE)
Drug Information of CIMETIDINE
| Product NDC: | 21695-531 |
| Proprietary Name: | CIMETIDINE |
| Non Proprietary Name: | CIMETIDINE |
| Active Ingredient(s): | 300 mg/1 & nbsp; CIMETIDINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CIMETIDINE
| Product NDC: | 21695-531 |
| Labeler Name: | Rebel Distributors Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075659 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19981218 |
Package Information of CIMETIDINE
| Package NDC: | 21695-531-21 |
| Package Description: | 21 TABLET in 1 BLISTER PACK (21695-531-21) |
NDC Information of CIMETIDINE
| NDC Code | 21695-531-21 |
| Proprietary Name | CIMETIDINE |
| Package Description | 21 TABLET in 1 BLISTER PACK (21695-531-21) |
| Product NDC | 21695-531 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CIMETIDINE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19981218 |
| Marketing Category Name | ANDA |
| Labeler Name | Rebel Distributors Corp |
| Substance Name | CIMETIDINE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
